DiaMedica Therapeutics (DMAC.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov14

Lake Street Analyst Maintains Buy Rating for DiaMedica Therapeutics, Sets Price Target at $14.00

14:37

Nov13

DiaMedica Therapeutics released FY2025 9 Months earnings on November 12 After-Market (EST), actual revenue USD 0, actual EPS USD -0.3591

00:00

DiaMedica Therapeutics released FY2025 Q3 earnings on November 12 After-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1736 (forecast USD -0.16)

00:00

Nov5

DiaMedica Therapeutics to Release FY2025 Q3 Earnings on November 12 After-Market EST, Forecast EPS -0.16 USD

00:05

Aug12

DiaMedica Therapeutics released FY2025 Q2 earnings on August 12 After-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1799 (forecast USD -0.19)

23:00

DiaMedica Therapeutics released FY2025 Semi-Annual earnings on August 12 After-Market EST, actual revenue USD 0, actual EPS USD -0.3591

23:00